Navigation Links
United Therapeutics Corporation To Announce Fourth Quarter And Annual 2012 Financial Results Before Market Open On Tuesday, February 26, 2013
Date:2/19/2013

SILVER SPRING, Md., Feb. 19, 2013 /PRNewswire/ -- United Therapeutics Corporation (NASDAQ: UTHR) announced today that it will release its fourth quarter and annual 2012 financial results before market open on Tuesday, February 26, 2013.

United Therapeutics will host a half-hour teleconference on Tuesday, February 26, 2013, at 9:00 a.m. Eastern Time.  The teleconference is accessible by dialing 1-877-351-5881, with international callers dialing 1-970-315-0533.  A rebroadcast of the teleconference will be available for one week and can be accessed by dialing 1-855-859-2056, with international callers dialing 1-404-537-3406, and using conference code: 89593584.

This teleconference is also being webcast and can be accessed via United Therapeutics' website at http://ir.unither.com/events.cfm.  [uthr-g]

United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of unique medicinal products.


'/>"/>
SOURCE United Therapeutics Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Animal Husbandry Equipment Market in United States: Business Report 2011
2. Strategic Analysis of the Collagen Peptide Market in the United States
3. GDS International Combines Top Healthcare Executives in the United States for its 10th Anniversary NG Healthcare Summit in May
4. United Therapeutics Announces Additional $100 Million Share Repurchase Program
5. United States Rocket Academy Welcomes XCOR Aerospace to Texas
6. United Therapeutics Corporation to Announce Second Quarter 2012 Financial Results Before Market Open on Thursday, July 26, 2012
7. New Approach to Growing Waste to Value Industry in United States
8. United Therapeutics Corporation Reports Second Quarter 2012 Financial Results
9. United Therapeutics Corporation To Announce Third Quarter 2012 Financial Results Before Market Open On Thursday, November 1, 2012
10. Recently Published Economic Analysis Highlights the Financial Impact of Attention-Deficit/Hyperactivity Disorder (ADHD) in the United States (US)
11. GlycoCheck Announces Partnership in the United States with Vascular Health Sciences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/1/2015)... 1, 2015 Esperance Pharmaceuticals Inc. today reported ... candidate EP-100 in ovarian cancer patients resistant to paclitaxel. ... and destroy cancer cells that overexpress luteinizing hormone-releasing hormone ... in a wide range of cancers. ... of EP-100 were presented at the 2015 ASCO ...
(Date:6/1/2015)... a biopharmaceutical company committed to uncovering health solutions through ... trials using its cancer drug BPM 31510 on Phase ... breast cancer, at the 51 st Annual Meeting ... 29 – June 2 in Chicago ... the first cancer drugs guided in development by artificial ...
(Date:6/1/2015)... BUFFALO, N.Y. , June 1, 2015 ... AMRI ) announced today that it has ... HarkerBIO LLC to co-market their structure-based drug ... clients. As part of the three-year agreement, ... high-resolution, structure-determination expertise and capabilities. HarkerBIO,s customers ...
(Date:6/1/2015)... DUBLIN , May 29, 2015 /PRNewswire/ ... announced the addition of the "2015 ... Market" report to their offering. ... tables, and provides a comprehensive analysis of ... dynamics, size, growth, regulatory requirements, technological trends, ...
Breaking Biology Technology:Esperance Reports Positive EP-100 Phase ll Results in Ovarian Cancer at 2015 ASCO Annual Meeting 2Esperance Reports Positive EP-100 Phase ll Results in Ovarian Cancer at 2015 ASCO Annual Meeting 3Berg Presents Data On BPM 31510 Solid Tumor Trial At ASCO Annual Meeting That Reveals The Promise Of Metabolically Driven Therapy 2Berg Presents Data On BPM 31510 Solid Tumor Trial At ASCO Annual Meeting That Reveals The Promise Of Metabolically Driven Therapy 3AMRI and HarkerBIO Ink Collaborative Agreement in Buffalo, N.Y. 2AMRI and HarkerBIO Ink Collaborative Agreement in Buffalo, N.Y. 3
... June 29 Palkion, Inc. announced today that it ... anemia therapeutic candidate that modulates the Hypoxia-Inducible Factor Prolyl ... founded when a novel drug discovery and development firm, ... capital firm, ProQuest Investments, formed a new joint venture ...
... MENLO PARK, Calif., June 29 Kornberg Associates | Architects ... Stanford University to design a new Cognitive & Neurobiological ... announcement. The firm has worked with Stanford University ... past 30 years, one of which is the two-story, 32,000 ...
... , BOTHELL, WA and VANCOUVER, June 26 /PRNewswire-FirstCall/ - ... today that it has filed a shelf registration statement ... Commission and an MJDS prospectus under the multi-jurisdictional disclosure ... is prudent for us to re-establish a three-year shelf ...
Cached Biology Technology:Palkion Selects Novel Oral Development Candidate for the Treatment of Anemia 2Palkion Selects Novel Oral Development Candidate for the Treatment of Anemia 3Kornberg Associates Architects Selected to Develop Design for New Stanford University Imaging Center 2OncoGenex Pharmaceuticals Files Shelf Registration Statement 2OncoGenex Pharmaceuticals Files Shelf Registration Statement 3OncoGenex Pharmaceuticals Files Shelf Registration Statement 4
(Date:5/18/2015)... 2015 Fingerprint Cards (FPC) has received ... FPC1155 and FPC1035 from one if its module partners. Deliveries ... Q3 2015 and the sensors will be used by smartphone ... for 2015 hereby amount to 740 MSEK to date. In ... MSEK and a number of smaller orders not separately communicated ...
(Date:5/11/2015)... , May 11, 2015  Synaptics Incorporated (NASDAQ: ... interface solutions, today announced the appointment of ... Chief Financial Officer, reporting to Rick Bergman ... current Chief Financial Officer, Kathleen Bayless , ... Mr. Ali brings extensive financial management ...
(Date:5/10/2015)... Fingerprint Cards (FPC) has received an ... the distributor World Peace Industrial Group (WPI), part of WPG ... Asia . Deliveries are planned to take place during ... manufacturers in China . The order value ... of + 1 000 MSEK for 2015.   Jörgen ...
Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2Synaptics Appoints Wajid Ali as Senior Vice President and Chief Financial Officer 2Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 235 Million 2
... Neurotechnology , a provider of high-precision biometric ... MegaMatcher 4.0 , a multi-biometric software development kit ... biometrics in a single, high-performance SDK that requires ... palmprint technology along with the latest versions of ...
... for making one species into two requires time and ... or something else that discourages gene flow between the ... Texas wildflowers that share meadows and roadside ditches, color-coding ... Robin Hopkins has found the first evidence of a ...
... The first commercial crop of a new mandarin variety ... will be harvested beginning later this month. The ... mutation of W. Murcott mandarin. Originally from Morocco, W. ... and tangy-sweet flavor traits shared by the Tango. ...
Cached Biology News:New MegaMatcher 4.0 from Neurotechnology Integrates Fingerprint, Iris, Facial and Palmprint Biometrics In One High-Performance SDK 2New MegaMatcher 4.0 from Neurotechnology Integrates Fingerprint, Iris, Facial and Palmprint Biometrics In One High-Performance SDK 3Wildflower colors tell butterflies how to do their jobs 2Tango mandarins to appear this month in produce aisles 2Tango mandarins to appear this month in produce aisles 3
BBS/Glycerol/Casein Block and Diluent - 10X Concentrate, 1 L...
... Immunogen: Synthetic peptide derived from an internal ... (Mammalian target of rapamycin FRAP RAFT1 RAPT1). ... protein. On Western blots it identifies ... Reactivity: Human (positive control: HEK293 cell lysates). ...
... to qualitatively detect EGFR ... paraffin-embedded (FFPE) tissue sections, ... cell preparations, using Chromogenic ... Fluorescent In Situ Hybridization ...
...
Biology Products: